Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Small Anim Pract ; 62(5): 336-342, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33521974

RESUMO

OBJECTIVES: The emergence of the 2019 novel coronavirus (SARS-CoV-2) has necessitated evaluation of the potential for SARS-CoV-2 infection in dogs and cats. Using a large data set, we evaluated the frequency of SARS-CoV-2 and other respiratory pathogens in samples submitted for respiratory testing from mid-February to mid-April 2020. MATERIALS AND METHODS: A SARS-CoV-2 real-time PCR was developed and validated. A subset of canine and feline samples submitted for respiratory pathogen panel testing to reference laboratories in Asia, Europe, and North America were also tested for SARS-CoV-2. The frequency of respiratory pathogens was compared for the February-April period of 2020 and 2019. RESULTS: Samples from 4616 patients were included in the study and 44% of canine and 69% of feline samples were PCR positive with Mycoplasma cynos and Bordetella bronchiseptica and Mycoplasma felis and feline calicivirus, respectively. No SARS-CoV-2 infections were identified. Positive results for respiratory samples were similar between years. CLINICAL SIGNIFICANCE: The data in this study suggest that during the emergence of the SARS-CoV-2 pandemic in early 2020, respiratory diseases in tested pet cats and dogs were caused by common veterinary pathogens and that SARS-CoV-2 infections in dogs and cats are rare.


Assuntos
COVID-19 , Doenças do Gato , Doenças do Cão , Animais , Ásia , COVID-19/veterinária , Doenças do Gato/diagnóstico , Doenças do Gato/epidemiologia , Gatos , Doenças do Cão/diagnóstico , Doenças do Cão/epidemiologia , Cães , Europa (Continente) , Mycoplasma , SARS-CoV-2
2.
J Small Anim Pract ; 45(11): 568-71, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15553196

RESUMO

Juvenile nephropathy has been documented in many breeds. Two related Pembroke Welsh corgi puppies presented at three and five months of age, respectively, for evaluation of lethargy, diarrhoea, poor body condition, polyuria and proteinuria. Based upon the clinical presentation, urinalysis and serum biochemistry, chronic renal failure was diagnosed. Renal histopathology was consistent with juvenile nephropathy, revealing lesions similar to the juvenile renal disease of dobermann dogs. To the authors' knowledge, this is the first report of juvenile nephropathy in related Pembroke Welsh corgi dogs. Familial nephropathy should now be considered as a differential diagnosis in cases of young Pembroke Welsh corgi dogs presenting with clinical signs indicating renal failure.


Assuntos
Doenças do Cão/diagnóstico , Falência Renal Crônica/veterinária , Rim/patologia , Animais , Análise Química do Sangue/veterinária , Cruzamento , Diagnóstico Diferencial , Doenças do Cão/genética , Doenças do Cão/patologia , Cães , Evolução Fatal , Falência Renal Crônica/diagnóstico , Falência Renal Crônica/genética , Falência Renal Crônica/patologia , Masculino
3.
J Am Vet Med Assoc ; 218(10): 1593-7, 1580, 2001 May 15.
Artigo em Inglês | MEDLINE | ID: mdl-11393371

RESUMO

A 9-year-old Bedlington Terrier was evaluated because of weight loss, inappetence, and hematemesis. Copper storage disease had been diagnosed previously on the basis of high hepatic copper concentration. Treatment had included dietary copper restriction and administration of trientine for chelation of copper. A CBC revealed microcytic hypochromic anemia. High serum activities of liver enzymes, high bile acid concentrations, and low BUN and albumin concentrations were detected. Vomiting resolved temporarily with treatment, but the clinicopathologic abnormalities persisted. Results of transcolonic portal scintigraphy suggested an abnormal shunt fraction. Results of liver biopsy and copper quantification revealed glycogen accumulation and extremely low hepatic copper concentration. Serum and hair copper concentrations were also low. Chelation and dietary copper restriction were tapered and discontinued. Clinical signs and all clinicopathologic abnormalities improved during a period of several months.


Assuntos
Quelantes/efeitos adversos , Terapia por Quelação/veterinária , Cobre/deficiência , Doenças do Cão/etiologia , Erros Inatos do Metabolismo dos Metais/veterinária , Trientina/efeitos adversos , Animais , Quelantes/uso terapêutico , Terapia por Quelação/efeitos adversos , Cobre/administração & dosagem , Cobre/metabolismo , Dieta/efeitos adversos , Dieta/veterinária , Doenças do Cão/dietoterapia , Doenças do Cão/tratamento farmacológico , Cães , Doença Iatrogênica/veterinária , Fígado/química , Masculino , Erros Inatos do Metabolismo dos Metais/dietoterapia , Erros Inatos do Metabolismo dos Metais/tratamento farmacológico , Fatores de Tempo , Trientina/uso terapêutico
4.
Am J Vet Res ; 61(9): 1150-5, 2000 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-10976751

RESUMO

UNLABELLED: OBJECTIVE-To characterize healing of corneal epithelial defects in horses and to evaluate the ability of epidermal growth factor (EGF) to modulate rate of corneal epithelial healing in horses. SAMPLE POPULATION: 20 eyes in 12 adult horses. PROCEDURE: Corneal epithelial wounds were created by mechanically debriding the limbus. Corneal healing was recorded for 3 treatment groups: 50 microg of EGF/ml (n = 5 eyes), 5 microg of EGF/ml (7), and PBS solution (8). Corneal healing was recorded once daily after instillation of fluorescein stain by use of photography and calculating the area of the wound, using imaging software. RESULTS: After corneal debridement, re-epithelialization was rapid and progressed in a linear fashion for the first 5 to 7 days after surgery in all groups. After that period, rates of healing decreased. A profound increase in the degree of inflammation, neovascularization, melanosis, and scarring was observed in eyes treated with the high dose of EGF (50 microg/ml), but there was not a statistical difference in mean healing time or in mean decrease in radius during the linear phase between the control and either EGF treatment groups. However, for all 8 horses in which both eyes were debrided, the first eye healed significantly faster than the second eye, regardless of treatment. CONCLUSIONS AND CLINICAL RELEVANCE: Beneficial effects of topical administration of a high dose of EGF for acceleration of healing of corneal defects in eyes of horses are outweighed by the intensity of the associated inflammatory response.


Assuntos
Doenças da Córnea/veterinária , Fator de Crescimento Epidérmico/uso terapêutico , Epitélio Corneano/lesões , Doenças dos Cavalos/tratamento farmacológico , Cicatrização/efeitos dos fármacos , Administração Tópica , Animais , Doenças da Córnea/tratamento farmacológico , Fator de Crescimento Epidérmico/administração & dosagem , Fator de Crescimento Epidérmico/efeitos adversos , Células Epiteliais/efeitos dos fármacos , Feminino , Cavalos , Humanos , Inflamação/induzido quimicamente , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA